Cooper CL, Hatashita H, Corsi DJ, Parmar P, Corrin R, Garber G

Idioma: Ingles.
Referencias bibliográficas: 24
Paginas: 874-880
Archivo PDF: 145.41 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Lloyd AR, Clegg J, Lange J, Stevenson A, Post JJ, Lloyd D, Rudge G, et al. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis 2013; 56:1078-84. doi: cis1202 [pii] 10.1093/cid/cis1202.

2. Nazareth S, Kontorinis N, Muwanwella N, Hamilton A, Leembruggen N, Cheng WS. Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealth. J Telemed Telecare 2013; 19: 101-6. doi: jtt.2012.120612 [pii] 10.1258/jtt.2012.120612.

3. Rossaro L, Aoki C, Yuk J, Prosser C, Goforth J, Martinez F. The evaluation of patients with hepatitis C living in rural California via telemedicine. Telemed J E Health 2008; 14: 1127- 9. doi: 10.1089/tmj.2008.0029.

4. Rossaro L, Torruellas C, Dhaliwal S, Botros J, Clark G, Li CS, Minoletti MM. Clinical outcomes of hepatitis C treated with pegylated interferon and ribavirin via telemedicine consultation in Northern California. Dig Dis Sci 2013; 58: 3620-5. doi: 10.1007/s10620-013-2810-y.

5. Yawn BP, Wollan P, Gazzuola L, Kim WR. Diagnosis and 10- year follow-up of a community-based hepatitis C cohort. J Fam Pract 2002; 51: 135-40. doi: jfp_0202_ [pii].

6. You A, Kawamoto J, Smith JP. A pharmacist-managed telemedicine clinic for hepatitis C care: a descriptive analysis. J Telemed Telecare 2014; 20: 99-101. doi: 1357633X13519043 [pii] 10.1177/1357633X13519043.

7. Young JD, Patel M, Badowski M, Mackesy-Amiti ME, Vaughn P, Shicker L, Puisis M, et al. Improved Virologic Suppression With HIV Subspecialty Care in a Large Prison System Using Telemedicine: An Observational Study With Historical Controls. Clin Infect Dis 2014. doi: ciu222 [pii] 10.1093/cid/ciu222.

8. Parmar P, Mackie D, Varghese S, Cooper C. Use of telemedicine technologies in the management of infectious diseases: a review. Clin Infect Dis 2015; 60: 1084-94. doi: 10.1093/ cid/ciu1143.

9. Arora S, Thornton K, Jenkusky SM, Parish B, Scaletti JV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep 2007; (122 Suppl. 2): 74-7.

10. Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, Parish B, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364: 2199-207. doi: 10.1056/NEJMoa1009370.

11. DeMaio J, Schwartz L, Cooley P, Tice A. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin Infect Dis 2001; 33: 2082-4. doi: CID010655 [pii] 10.1086/324506.

12. DeMaio J, Sharma D. Tuberculosis therapy and telemedicine. Expert Opin Pharmacother 2002; 3: 1283-8. doi: 10.1517/ 14656566.3.9.1283.

13. Gassanov MA, Feldman LJ, Sebastian A, Kraguljac MJ, Rea E, Yaffe B. The use of videophone for directly observed therapy for the treatment of tuberculosis. Can J Public Health 2013; 104: e272.

14. Khatri K, Haddad M, Anderson D. Project ECHO: replicating a novel model to enhance access to hepatitis C care in a community health center. J Health Care Poor Underserved 2013; 24: 850-8. doi: S154868691320032X [pii] 10.1353/ hpu.2013.0093.

15. Rossaro L, Tran TP, Ransibrahmanakul K, Rainwater JA, Csik G, Cole SL, Prosser CC, et al. Hepatitis C videoconferencing: the impact on continuing medical education for rural healthcare providers. Telemed J E Health 2007; 13: 269-77. doi: 10.1089/tmj.2006.0050.

16. 16. Saifu HN, Asch SM, Goetz MB, Smith JP, Graber CJ, Schaberg D, Sun BC. Evaluation of human immunodeficiency virus and hepatitis C telemedicine clinics. Am J Manag Care 2012; 18: 207-12. doi: 63938 [pii].

17. Wade VA, Karnon J, Eliott JA, Hiller JE. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation. PLoS One 2012; 7: e50155. doi: 10.1371/journal.pone.0050155 PONE-D-12-16544 [pii].

18. Elbert NJ, van Os-Medendorp H, van Renselaar W, Ekeland AG, Hakkaart-van Roijen L, Raat H, Nijsten TE, et al. Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-analyses. J Med Internet Res 2014; 16: e110. doi: v16i4e110 [pii] 10.2196/jmir.2790.

19. Eron L. Telemedicine: the future of outpatient therapy? Clin Infect Dis 2010; (51 Suppl. 2): S224-30. doi: 10.1086/ 653524.

20. Public Health Agency of Canada: Hepatitis C in Canada: 2005-2010 Surveillance Report. In: Centre for Communicable Diseases and Infection Control; Infectious Disease Prevention and Control Branch ed.: Public Health Agency of Canada, 2011.

21. Statistics Canada. Census Profile. Available at: URL. Access: December 2 2016.

22. Pampalon R, Hamel D, Gamache P, Raymond G. A deprivation index for health planning in Canada. Chronic Dis Can 2009; 29: 178-91.

23. Leon A, Caceres C, Fernandez E, Chausa P, Martin M, Codina C, Rousaud A, et al. A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS One 2011:(6):e14515. doi: 10.1371/journal.pone.0014515.

24. Marshall AD, Saeed S, Barrett L, Cooper CL, Treloar C, Bruneau J, Feld JJ, et al. Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study. CMAJ Open 2016; 4: E605- E614. doi: 10.9778/cmajo.20160008.